23071869|t|Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.
23071869|a|A double blind, placebo-controlled phase II study revealed that the antihistamine, Dimebon  (dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients compared to placebo controls. However, the Phase III CONNECTION trial failed to demonstrate significant differences between dimebon and placebo treatments. Despite the controversial therapeutic outcomes in the treatment of AD, dimebon's mechanism(s) of action within the brain remain unclear. In the present study, we evaluated the effects of dimebon upon beta-amyloid (Abeta), tau and astrocytes in the hippocampus of triple transgenic (3xTg-AD) mice, which develop AD-like pathology in an age-dependent manner. At age 6.5 months, prior to the development of Abeta plaques in the hippocampus, male and female 3xTg-AD mice, received a daily intraperitoneal injection of 0.1 % dimebon or saline for 1.5 months. At 8 months, quantitative immunohistochemistry revealed a significant reduction in hippocampal/subicular APP/Abeta in dimebon-treated mice, whereas protein bioassay found no change in full length APP, soluble Abeta(1-40) and Abeta(1-42), Abeta oligomers, BACE1 and GFAP levels between groups. Interestingly, the number of the hippocampal APP/Abeta plaques in female and male dimebon-treated mice was higher compared to gender-matched control mice. Dimebon did not alter hippocampal tau levels. Furthermore, dimebon protects SH-SY5Y neurons against Abeta toxicity and promotes GFAP expression in primary mouse astrocyte cultures. Our findings demonstrate that dimebon in vivo modifies hippocampal APP/Abeta pathology and in vitro protects against Abeta toxicity promoting cell survival and activates astrocytes.
23071869	0	7	Dimebon	Chemical	MESH:C010119
23071869	15	26	hippocampal	Disease	MESH:D000092223
23071869	27	34	amyloid	Disease	MESH:C000718787
23071869	48	52	3xTg	Disease	
23071869	53	55	AD	Disease	MESH:D000544
23071869	56	60	mice	Species	10090
23071869	145	152	Dimebon	Chemical	MESH:C010119
23071869	155	164	dimebolin	Chemical	MESH:C010119
23071869	166	178	latrepirdine	Chemical	MESH:C010119
23071869	202	219	Alzheimer disease	Disease	MESH:D000544
23071869	221	223	AD	Disease	MESH:D000544
23071869	225	233	patients	Species	9606
23071869	287	297	CONNECTION	Disease	MESH:D003240
23071869	358	365	dimebon	Chemical	MESH:C010119
23071869	457	459	AD	Disease	MESH:D000544
23071869	461	468	dimebon	Chemical	MESH:C010119
23071869	577	584	dimebon	Chemical	MESH:C010119
23071869	604	609	Abeta	Gene	11820
23071869	672	676	3xTg	Disease	
23071869	677	679	AD	Disease	MESH:D000544
23071869	681	685	mice	Species	10090
23071869	701	703	AD	Disease	MESH:D000544
23071869	794	799	Abeta	Gene	11820
23071869	844	848	3xTg	Disease	
23071869	849	851	AD	Disease	MESH:D000544
23071869	852	856	mice	Species	10090
23071869	910	917	dimebon	Chemical	MESH:C010119
23071869	1027	1038	hippocampal	Disease	MESH:D000092223
23071869	1053	1058	Abeta	Gene	11820
23071869	1062	1069	dimebon	Chemical	MESH:C010119
23071869	1078	1082	mice	Species	10090
23071869	1182	1187	Abeta	Gene	11820
23071869	1199	1204	BACE1	Gene	23821
23071869	1209	1213	GFAP	Gene	14580
23071869	1270	1281	hippocampal	Disease	MESH:D000092223
23071869	1286	1291	Abeta	Gene	11820
23071869	1319	1326	dimebon	Chemical	MESH:C010119
23071869	1335	1339	mice	Species	10090
23071869	1386	1390	mice	Species	10090
23071869	1392	1399	Dimebon	Chemical	MESH:C010119
23071869	1414	1425	hippocampal	Disease	MESH:D000092223
23071869	1451	1458	dimebon	Chemical	MESH:C010119
23071869	1468	1475	SH-SY5Y	CellLine	CVCL:0019
23071869	1492	1497	Abeta	Gene	11820
23071869	1498	1506	toxicity	Disease	MESH:D064420
23071869	1520	1524	GFAP	Gene	14580
23071869	1547	1552	mouse	Species	10090
23071869	1603	1610	dimebon	Chemical	MESH:C010119
23071869	1628	1639	hippocampal	Disease	MESH:D000092223
23071869	1644	1649	Abeta	Gene	11820
23071869	1690	1695	Abeta	Gene	11820
23071869	1696	1704	toxicity	Disease	MESH:D064420
23071869	Association	MESH:C010119	MESH:C000718787
23071869	Negative_Correlation	MESH:C010119	MESH:D000092223
23071869	Positive_Correlation	MESH:C010119	14580
23071869	Association	MESH:D000092223	11820
23071869	Negative_Correlation	MESH:C010119	11820
23071869	Negative_Correlation	MESH:C010119	MESH:D000544
23071869	Negative_Correlation	MESH:C010119	MESH:D064420

